Study of Minnelide™ in Patients With Advanced GI Tumors
A Phase II, International Open Label Trial of Minnelide™ in Patients With Refractory Pancreatic Cancer
|3||Not yet recruiting||
A Phase I, Multicenter, Open-label, Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of Minnelide™Capsules in Patients With Advanced Solid Tumors
† Study has passed its completion date and status has not been verified in more than two years.